Back to Careers

Gayathri Swaminath, PhD, MBA


Gayathri Swaminath, PhD, MBA brings over 17 years of preclinical, translational research & drug development experience in the pharmaceutical industry. Dr. Swaminath has strong drug discovery expertise in multiple therapeutic areas including diabetes, cardiovascular, fibrosis, inflammation, ophthalmology, oncology, immunology, pulmonary hypertension & renal diseases. Prior to joining Juvena Therapeutics, she served as Vice President for Research & Business Development at GreenfireBio, overseeing nonclinical & clinical development efforts for an oncology program, including fund raising & in-licensing activities. As a co-founder of MGFB Bio, she led the immuno-oncology preclinical activities for a cancer vaccine platform.

She was a Director in Cardiometabolic at Merck Research Laboratories, with previous leadership roles at Amgen. At Merck, & Amgen, she contributed to the preclinical pipeline in several therapeutic areas and advanced small molecules to the clinic, including Verquvo for heart failure. She has co-authored 35 publications in peer-reviewed journals, a book chapter, and holds several patents. As an invited speaker, she has presented at many national & international conferences. Dr. Swaminath completed her Ph.D. in Biochemistry from the University of Hyderabad, India, postdoctoral fellowship at Stanford University, and holds an MBA from Cornell University.


Learn more about Dr. Gayathri Swaminath